Obutinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Obutinib, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]